Seeing Is Believing
Healthcare - Sector
with an average price target of $3.93. This is a potential upside of $2.61 (197.73%) from yesterday's end of day stock price of $1.32.
Marker Therapeutics's activity chart (see below) currently has 8 price targets and 10 ratings on display.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 113.75 days.
Most recent stock forecast was given by AYDIN HUSEYNOV from LADENBURG on 21-Oct-2024. First documented stock forecast 22-Oct-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$11
$9.68 (733.33%)
$11
1 years 5 months 15 days ago
(21-Oct-2024)
0/2 (0%)
$7.3 (197.30%)
Buy Since 25-Mar-2021
$40
3 years 10 months 9 days ago
(27-May-2022)
0/2 (0%)
$35.43 (775.27%)
Buy Since 03-Jul-2019
4 years 1 months 19 days ago
(17-Feb-2022)
1/1 (100%)
$-67.3 (-81.77%)
455
Buy Since 11-Feb-2020
$60
$58.68 (4445.45%)
5 years 11 days ago
(25-Mar-2021)
0/2 (0%)
$35 (140.00%)
What is MRKR (Marker Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MRKR (Marker Therapeutics) with a proven track record?
Which analyst has the current lower performing score on MRKR (Marker Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MRKR (Marker Therapeutics)?
Which analyst is the currently most bullish on MRKR (Marker Therapeutics)?
Which analyst is the currently most reserved on MRKR (Marker Therapeutics)?